Jazz Luna likely to win Cancer Trophy
Jazz Luna looks to be confident enough to clinch top spot in the Coral Supports Macmillan Cancer Trophy that will go down at Romford racecourse on Friday night, May 18. The action is scheduled to commence at 22:40 (GMT).
To cover the distance of 750 meters, the M. Locke-trained black b***h will test her racing credentials against Benro Spot, Starry Eyes, Aclamon Tracey, Fabulous Drama and Balmi Blue. The Open Race contains £200 in the prize purse.
The brilliant b***h has been at the peak of form since the very beginning of 2012. After getting a runner-up rank on January 7, the veteran hound bagged a couple of consecutive victories in April. She moved on to finish first in a race on April 28.
The talented sprinter elegantly grabbed a second and a first position in the first half of May. Thus, the daughter of Westmead Hawk out of Jazz Hurricane is carrying immense winning momentum that will lend a great hand to her in today’s marathon.
If Jazz Luna runs to her best and avoids making any mistake on the track, she will have up to 90 percent chances to finish first.
Among the other runners, Balmi Blue and Aclamon Tracey are likely to perform well in the Trophy.
Balmi Blue excellently claimed top spot in a race on April 25, 2012. The D. Mullins-trained blue dog stepped ahead to finish 2nd in a race each on May 3 and 12. The dashing dog holds the highest odds in the betting market. He can give a tough time to Jazz Luna.
Aclamon Tracey has been winning with regular intervals since the beginning of the calendar year. After winning a couple of races each in February and March, the E. Gaskin-trained brindle b***h finished first by the huge margin of 9 ¾ lengths on April 28.
In this situation, there will be a tough tug of war for the Trophy title. Jazz Luna will have to fight hard in order to thrive. Let us go for a fabulous action. Good luck to all the contestants who are set to run today.
Disclaimer: The views expressed in this article are the writer's own and do not reflect Bettor.Com’s editorial policy.
Tags: